SODIUM (E)-(3-(4-FORMYLBENZYLIDENE)-7,7-DIMETHYL-2-OXOBICYCLO(2.2.1)HEPTAN-1-YL)METHANESULFONATE
UNII 035QR53X3X
Substance Identification & Data
This profile provides standardized clinical and technical data for Sodium (e)-(3-(4-formylbenzylidene)-7,7-dimethyl-2-oxobicyclo(2.2.1)heptan-1-yl)methanesulfonate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 035QR53X3X.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C18H19O5S.Na VHIRFFDSSUIJQZ-KYIGKLDSSA-M Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Sodium (e)-(3-(4-formylbenzylidene)-7,7-dimethyl-2-oxobicyclo(2.2.1)heptan-1-yl)methanesulfonate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.